Legal status by country
Is GLOW capsules legal?
Written by Aaron CuhaReviewed Sep 2026
How GLOW capsules is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | Marketed as a supplement; BPC-157 was placed on FDA's list of substances that present significant safety risks for compounding, and is not a lawful dietary ingredient. | Not a licensed medicine and not an authorised novel food ingredient. | None recorded | None recorded |
US FDA status: Not approved as a drug. Sold as a supplement despite containing peptides FDA has placed outside the compounding lists, which is a regulatory position vendors assert rather than one a regulator has granted.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.